103 related articles for article (PubMed ID: 5705454)
1. [On the effect of the beta-receptor blocking agent propranolol in patients with coronary insufficienct].
Nossing R; Gruber G
Z Gesamte Inn Med; 1968 Nov; 23(21):675-9. PubMed ID: 5705454
[No Abstract] [Full Text] [Related]
2. [Action of propranolol, beta-adrenergic blocking agent, on disorders of cardiac rhythm].
Sánchez A; Cárdenas M; Shapiro M
Arch Inst Cardiol Mex; 1967; 37(1):47-62. PubMed ID: 6058090
[No Abstract] [Full Text] [Related]
3. [Therapeutic use of beta-receptor blocking agents].
Wallnöfer H; Bereitter E
Wien Klin Wochenschr; 1968 Apr; 80(15):288-92. PubMed ID: 5688615
[No Abstract] [Full Text] [Related]
4. [Stress studies of patients with coronary insufficiency receiving a beta blockader with reference to the beta-sympathicolytic blood level behavior].
Otten H; Gugler R; Bodem G
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1735-8. PubMed ID: 347798
[No Abstract] [Full Text] [Related]
5. [Therapeutic use of beta-adrenergic blocking agents].
Renner C; Rouffy J
Presse Med (1893); 1967 Jul; 75(32):1651-3. PubMed ID: 6027505
[No Abstract] [Full Text] [Related]
6. [Use of propranolol in coronary insufficiency and in some cardiac arrhythmias].
Zavala Jurado A; Gonzalez Martin A; De Feuillade ND; Liñan JM
Prensa Med Argent; 1968 Aug; 55(26):1271-8. PubMed ID: 4974565
[No Abstract] [Full Text] [Related]
7. [Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
Fassini G; Saurgnani E; Agliati G; Marangoni R
Minerva Cardioangiol; 1967 Jan; 15(1):83-122. PubMed ID: 4386133
[No Abstract] [Full Text] [Related]
8. [Proceedings: Exercise plethysmography in patients with ischemic heart diseases--the effect of propranolol].
Yasue H; Tanaka A; Morita M
Jpn Circ J; 1975 Apr; 39(4):505. PubMed ID: 1121117
[No Abstract] [Full Text] [Related]
9. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
Piva M; Ongari R
Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
[No Abstract] [Full Text] [Related]
10. [Use of beta blockaders in patients with ischemic heart disease during in-hospital rehabilitation after aortocoronary bypass surgery].
Osanova MV; Malikov VE; Rogov SV; Petrunina LV
Klin Med (Mosk); 1994; 72(2):25-8. PubMed ID: 8015235
[TBL] [Abstract][Full Text] [Related]
11. [Use of obzidan in continuous cardiac fibrillation and extrasystole in middle-aged and elderly patients with ischemic heart disease].
Korkushko OV; Butenko AG
Klin Med (Mosk); 1983 Nov; 61(11):34-40. PubMed ID: 6198556
[No Abstract] [Full Text] [Related]
12. [Protective action in rats of propranolol injected jointly with aminophylline against electrocardiographic changes induced by pitressin].
Setti L; Razzaboni G
Boll Soc Ital Biol Sper; 1969 Oct; 45(19):1226-7. PubMed ID: 5396329
[No Abstract] [Full Text] [Related]
13. Uses of propranolol in diagnosis and therapy of circulatory diseases.
Wasyluk J
Mater Med Pol; 1974; 6(4):325-8. PubMed ID: 4453159
[No Abstract] [Full Text] [Related]
14. Effects of propranolol on coronary insufficiency at work test.
Areskog NH
Mal Cardiovasc; 1969; 10(1):41-5. PubMed ID: 5378977
[No Abstract] [Full Text] [Related]
15. [Beta-receptor blocking agent in parasystole following artificial pacemaker implantation].
Avenhaus H; Grohmann H; Nordmann KJ
Z Kreislaufforsch; 1967 Oct; 56(10):1051-64. PubMed ID: 5592253
[No Abstract] [Full Text] [Related]
16. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on the therapeutic value of propranolol (Inderal) in diseases of the circulatory system].
Szulc EJ
Przegl Lek; 1967 Jul; 23(7):593-6. PubMed ID: 6062562
[No Abstract] [Full Text] [Related]
18. Improving physical fitness of coronary disease patients on beta-blocking therapy.
McGhee JR; Siconolfi SF; Carleton RA; Bouchard P
J Am Osteopath Assoc; 1985 May; 85(5):318-21. PubMed ID: 4044325
[No Abstract] [Full Text] [Related]
19. [Effects of beta adrenergic receptor blockaders studied with propranolol on the ventricular repolarizzation in patients with hypertensive heart disease and chronic coronary insufficiency].
Zani D; Melara D
Cardiol Prat; 1969 Jun; 20(3):211-27. PubMed ID: 5407605
[No Abstract] [Full Text] [Related]
20. [Use of adrenergic beta-receptor blocking agents in disturbance of heart rhythm].
Moissejew S; Ustinowa E
Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):406-7. PubMed ID: 4882606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
